We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

66 hedge funds and large institutions have $91.4M invested in Viking Therapeutics in 2018 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

825% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 4

249% more call options, than puts

Call options by funds: $747K | Put options by funds: $214K

141% more capital invested

Capital invested by funds: $37.9M → $91.4M (+$53.4M)

114% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 7

100% more funds holding

Funds holding: 33 → 66 (+33)

14.43% more ownership

Funds ownership: 26.64% → 41.07% (+14%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
66
Holders Change
+33
Holders Change %
+100%
% of All Funds
1.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
37
Increased
15
Reduced
7
Closed
4
Calls
$747K
Puts
$214K
Net Calls
+$533K
Net Calls Change
+$533K

Top Buyers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
+$17.6M
2
RCM
RA Capital Management
Massachusetts
+$11.2M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$9.01M
4
PC
Polar Capital
United Kingdom
+$4.15M
5
Millennium Management
Millennium Management
New York
+$3.85M

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$3.06M
2
PVI
Pura Vida Investments
New York
-$1.43M
3
PWAM
Park West Asset Management
California
-$553K
4
Renaissance Technologies
Renaissance Technologies
New York
-$392K
5
EI
EAM Investors
California
-$351K
Name Holding Trade Value Shares
Change 		Change in
Stake
Creative Planning
26
Creative Planning
Kansas
$385K +$100K +18,140 +26%
TEE
27
Tibra Equities Europe
United Kingdom
$384K +$486K +87,791 New
CC
28
Cornerstone Capital
California
$379K – – –
Northern Trust
29
Northern Trust
Illinois
$345K +$215K +38,901 +97%
PPA
30
Parametric Portfolio Associates
Washington
$311K +$393K +71,096 New
IBT
31
International Biotechnology Trust
United Kingdom
$305K – – –
SIM
32
Spark Investment Management
New York
$294K +$373K +67,450 New
TI
33
Trexquant Investment
Connecticut
$281K +$356K +64,413 New
UBS Group
34
UBS Group
Switzerland
$277K +$295K +53,329 +533%
ERSOT
35
Employees Retirement System of Texas
Texas
$271K +$343K +62,000 New
LCM
36
Laurion Capital Management
New York
$218K +$277K +49,986 New
AGM
37
Alpine Global Management
New York
$175K – – –
State Street
38
State Street
Massachusetts
$140K +$176K +31,900 New
GIP
39
Granite Investment Partners
California
$140K +$177K +32,068 New
Group One Trading
40
Group One Trading
Illinois
$127K +$160K +28,959 New
Bank of New York Mellon
41
Bank of New York Mellon
New York
$110K +$140K +25,298 New
JG
42
Jefferies Group
New York
$89K +$112K +20,300 New
Two Sigma Advisers
43
Two Sigma Advisers
New York
$82K +$104K +18,800 New
BIM
44
Bogle Investment Management
Massachusetts
$80K +$102K +18,407 New
Bank of America
45
Bank of America
North Carolina
$71K +$90K +16,276 New
Citadel Advisors
46
Citadel Advisors
Florida
$65K +$82.8K +14,975 New
Barclays
47
Barclays
United Kingdom
$64K +$71.9K +12,988 +771%
Morgan Stanley
48
Morgan Stanley
New York
$56K +$71.3K +12,881 New
IGGA
49
Iron Gate Global Advisors
Utah
$53K +$7.03K +1,270 +12%
GC
50
Guggenheim Capital
Illinois
$52K +$66.3K +11,988 New
1
2
3

VKTX Hedge Fund Activity: Q1 2018 in Review

66 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q1 2018, worth a combined $91.4M — up 141% from $37.9M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new VKTX positions and 4 closed out — a net gain of 33 holders — while 15 added to existing stakes and 7 trimmed.

The largest buyer was Boxer Capital, opening a new position worth an estimated $17.6M. The largest seller was Sphera Funds Management, cutting an estimated $3.06M.

  • 66 institutional investors held Viking Therapeutics (VKTX) as of Q1 2018, up from 33 in Q4 2017.
  • Funds reported $91.4M of Viking Therapeutics stock for Q1 2018, up 141% quarter-over-quarter.
  • 37 funds opened new Viking Therapeutics positions in Q1 2018 and 4 closed out, a net change of +33 holders.
  • The largest Viking Therapeutics buyer in Q1 2018 was Boxer Capital, an estimated $17.6M added.
  • The largest Viking Therapeutics seller in Q1 2018 was Sphera Funds Management, an estimated $3.06M sold.

Based on aggregated 13F filings for Q1 2018.